Your browser doesn't support javascript.
loading
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001.
Kahn, Justine M; Cole, Peter D; Blonquist, Traci M; Stevenson, Kristen; Jin, Zhezhen; Barrera, Sergio; Davila, Randy; Roberts, Emily; Neuberg, Donna S; Athale, Uma H; Clavell, Luis A; Laverdiere, Caroline; Leclerc, Jean-Marie; Michon, Bruno; Schorin, Marshall A; Welch, Jennifer J G; Sallan, Stephen E; Silverman, Lewis B; Kelly, Kara M.
Afiliação
  • Kahn JM; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Medical Center, New York, New York.
  • Cole PD; Division of Pediatric Hematology/Oncology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York.
  • Blonquist TM; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Stevenson K; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Jin Z; Department of Biostatistics, Columbia University Medical Center, New York, New York.
  • Barrera S; Department of Economics, University of Minnesota, Minneapolis, Minnesota.
  • Davila R; Department of Psychology, University of California, Davis, California.
  • Roberts E; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.
  • Neuberg DS; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Athale UH; Division of Pediatric Hematology/Oncology, McMaster University, Hamilton, Ontario, Canada.
  • Clavell LA; Division of Pediatric Oncology, San Jorge Children's Hospital, San Juan, Puerto Rico.
  • Laverdiere C; Division of Hematology and Oncology, Hospital Sainte-Justine, University of Montreal, Montreal, Canada.
  • Leclerc JM; Division of Hematology and Oncology, Hospital Sainte-Justine, University of Montreal, Montreal, Canada.
  • Michon B; Division of Hematology-Oncology, Centre Hospitalier de l'Université Laval, Quebec City, Canada.
  • Schorin MA; Inova Fairfax Hospital for Children, Falls Church, Virginia.
  • Welch JJG; Division of Pediatric Hematology-Oncology, Hasbro Children's Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
  • Sallan SE; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts.
  • Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, Massachusetts.
  • Kelly KM; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Medical Center, New York, New York.
Pediatr Blood Cancer ; 65(3)2018 03.
Article em En | MEDLINE | ID: mdl-29090520
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteonecrose / Hispânico ou Latino / Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteonecrose / Hispânico ou Latino / Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2018 Tipo de documento: Article